Skip to main content

BioInquire Gets STTR Grant

NEW YORK (GenomeWeb News) – BioInquire, an Athens, Ga.-based bioinformatics company, said today that is has won a $747,000 Phase II Small Business Technology Transfer grant.

The company plans to use the two-year National Institutes of Health grant to continue to develop its ProteoIQ software suite. The software is designed and distributed for use in academic, pharmaceutical, biotechnology, and molecular diagnostic labs that use mass spectrometry proteomics research techniques.

"While software applications exist for validation and quantitation of MS/MS data, no current product adequately addresses the needs of researchers doing large scale clinical proteomics," James Atwood, co-founder and CEO of BioInquire, said in a statement. "The award will allow us to bridge that technology gap by providing a software solution that will enable the comparison of proteomic data across hundreds of patients."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.